Cell-free DNA Analysis of Chromosome Anomalies in Early Pregnancy Loss

Early Pregnancy Loss Clinical Trial

Official title:
Cell-free DNA Analysis of Chromosome Anomalies in Early Pregnancy Loss

Status Terminated

Clinical Trial Summary

The study assesses the accuracy of cell-free DNA (cfDNA) analysis in detecting whole chromosomal aneuploidies from maternal plasma of patients with early, missed miscarriage.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04935138
Study type	Observational
Source	Quest Diagnostics-Nichols Insitute
Contact
Status	Terminated
Phase
Start date	June 1, 2021
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04595760` - Factors Influencing Fertility or Pregnancy Health
Completed	`NCT01132924` - A Follow-up of the Early Pregnancy Study Cohort.
Recruiting	`NCT05880381` - Virtual Reality for Coping With Involuntary Early Pregnancy Loss	N/A
Completed	`NCT04410029` - Evaluation of a Decision Aid for Early Pregnancy Loss	N/A
Not yet recruiting	`NCT06452719` - Letrozole and Misoprostol for Early Pregnancy Loss Management: A Prospective Pilot Cohort Study	Phase 2
Recruiting	`NCT04738370` - Assessment of Biomarkers in Pregnancy on Unknown Location and Ectopic Pregnancy
Not yet recruiting	`NCT06309927` - Operative Hysteroscopy Versus Suction Curettage for Surgical Termination of Early Pregnancy Loss (Miscarriage)	N/A